MedTrace Logo

Feasibility of Placing Bravo PH Capsule in Proximal Esophagus

NCT00378898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2017-04-04

Study results available
· View outcomes & findings →

Summary

Assessing the feasibility and patient tolerance to placement of Bravo PH capsule in proximal esophagus.

There will be no difference in patient-perception of a proximally-placed Bravo esophageal pH monitor compared with a distal monitor.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

DEVICE

BRAVO capsule

PROCEDURE

Fluoroscopy

one time "xray" to determine evacuation of bravo

OTHER

sham BRAVO capsule placement

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Michael F Vaezi, MD, PhD · Vanderbilt University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2009-03-31
Completion
2009-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00378898 on ClinicalTrials.gov